T1	Participants 56 93	AJCC/UICC stage II colorectal cancer.
T2	Participants 357 474	patients with American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) stage II disease.
T3	Participants 483 585	Tumors of 120 randomly selected patients with AJCC/UICC stage II disease were retrospectively reviewed
T4	Participants 590 625	tumor growth pattern (expanding vs.
T5	Participants 626 639	infiltrating)
T6	Participants 1804 1865	outcome in patients with AJCC/UICC stage II colorectal cancer
